Entry ID | Original Release date | Data summary | Entry Title | Citation Title | Authors |
---|---|---|---|---|---|
31023 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
Solution NMR structure of 8-residue Rosetta-designed cyclic peptide D8.21 in CDCl3 with cis/trans switching (TC conformation, 53%) | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
31022 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 2 sets |
Solution NMR structure of 8-residue Rosetta-designed cyclic peptide D8.21 in 50% d6-DMSO and 50% water with cis/trans switching (CC conformation, 50%) | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
31021 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
Solution NMR structure of 8-residue Rosetta-designed cyclic peptide D8.31 in d6-DMSO with cis/trans switching (B-CT conformation) | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
31019 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
Solution NMR structure of 9-residue Rosetta-designed cyclic peptide D9.16 in CDCl3 with cis/trans switching (B-TC conformation) | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
31003 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
Solution NMR structure of 8-residue Rosetta-designed cyclic peptide D8.21 in CDCl3 with cis/trans switching | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
30997 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
Solution NMR structure of 9-residue Rosetta-designed cyclic peptide D9.16 in d6-DMSO with cis/trans switching | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
30998 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
Solution NMR structure of 8-residue Rosetta-designed cyclic peptide D8.31 in d6-DMSO with cis/trans switching | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
30999 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
Solution NMR structure of 8-residue Rosetta-designed cyclic peptide D8.21 in d6-DMSO with cis/trans switching | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
31000 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 2 sets |
Solution NMR structure of 8-residue Rosetta-designed cyclic peptide D8.21 in 50% d6-DMSO and 50% water with cis/trans switching | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
31001 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
Solution NMR structure of 9-residue Rosetta-designed cyclic peptide D9.16 in CDCl3 with cis/trans switching | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
31002 | 2022-09-08 | Chemical Shifts: 1 set Spectral_peak_list: 1 set |
Solution NMR structure of 8-residue Rosetta-designed cyclic peptide D8.31 in CDCl3 with cis/trans switching | Accurate de novo design of membrane-traversing macrocycles | A K Bera, A Lauko, C Glynn, D Baker, D Craik, G Bhardwaj, G G Alpkilic, G T Montelione, J O'Connor, J Palmer, J Rodriguez, L L Dong, L Stewart, M Bick, M Di Piazza, P Hosseinzadeh, R Choi, R Griffin, R Tejero, S Rettie, T A Ramelot, T W Craven, V K Mulligan, W van Voorhis, X Li, Y H Huang |
30724 | 2020-04-27 | Chemical Shifts: 1 set |
Cap1G-TPUA | Structural basis for transcriptional start site control of HIV-1 RNA fate | Aishwarya S Iyer, Alice Telesnitsky, Bryce Edwards, David A Case, Dillion Francis, Frances Grace G Ghinger, Ghazal Becker, Hannah Carter, Issac Chaudry, Jana Hijji, Joshua D Brown, Kailan Stewart, Karndeep Singh, Lindsay Glang, Matthew Orellana, Michael F Summers, Michael W Lopresti, Patrick Chen, Seung H Choi, Siarhei Kharytonchyk, Tatiana Rodriguez, Ubiomo Oboh, Yash Desai |
30723 | 2020-04-27 | Chemical Shifts: 1 set |
Cap3G-TAR-F1 | Structural basis for transcriptional start site control of HIV-1 RNA fate | Aishwarya S Iyer, Alice Telesnitsky, Bryce Edwards, David A Case, Dillion Francis, Frances Grace G Ghinger, Ghazal Becker, Hannah Carter, Issac Chaudry, Jana Hijji, Joshua D Brown, Kailan Stewart, Karndeep Singh, Lindsay Glang, Matthew Orellana, Michael F Summers, Michael W Lopresti, Patrick Chen, Seung H Choi, Siarhei Kharytonchyk, Tatiana Rodriguez, Ubiomo Oboh, Yash Desai |
27682 | 2020-02-28 | Chemical Shifts: 1 set |
Backbone amide and AILV methyl chemical shift assignments for H2-Ld, a mouse class I major histocompatibility molecule heavy chain | Molecular determinants of chaperone interactions on MHC-I for folding and antigen repertoire selection | Andrew C McShan, Christine A Devlin, Danai Moschidi, David Flores-Solis, Erik Procko, Hannah Choi, Jihye Park, Jugmohit S Toor, Nikolaos G Sgourakis, Sarah A Overall, Sarvind Tripathi |
36133 | 2018-12-13 | Chemical Shifts: 1 set |
Solution structure of BCL-XL bound to P73-TAD peptide | Cytoplasmic pro-apoptotic function of the tumor suppressor p73 is mediated through a modified mode of recognition of the anti-apoptotic regulator Bcl-XL. | B C Park, B Kim, B-Y, D Lee, D-H, J Ha, J-H, J H Cho, J Kim, J-H, J Lee, J-Y, J S Choi, J Song, K Bae, K-H, M Lee, M-K, M Lee, M-S, M Yoon, M-K, S A Kim, S Chi, S-W, S G Park, S Kim, S U Choi |
27631 | 2018-11-01 | Chemical Shifts: 1 set |
Backbone amide and AILV methyl chemical shift assignments for HLA-A*02:01, a human class I major histocompatibility molecule heavy chain. | Molecular determinants of chaperone interactions on MHC-I for folding and antigen repertoire selection | Andrew C McShan, Christine A Devlin, Danai Moschidi, David Flores-Solis, Erik Procko, Hannah Choi, Jihye Park, Jugmohit S Toor, Nikolaos G Sgourakis, Sarah A Overall, Sarvind Tripathi |
27632 | 2018-11-01 | Chemical Shifts: 2 sets |
Backbone amide and AILV methyl chemical shift assignments for HLA-A*01:01, a human class I major histocompatibility molecule heavy chain | Molecular determinants of chaperone interactions on MHC-I for folding and antigen repertoire selection | Andrew C McShan, Christine A Devlin, Danai Moschidi, David Flores-Solis, Erik Procko, Hannah Choi, Jihye Park, Jugmohit S Toor, Nikolaos G Sgourakis, Sarah A Overall, Sarvind Tripathi |
5528 | 2003-07-07 | Chemical Shifts: 1 set |
Solution structure of the complementary RNA promoter of influenza a virus | Solution Structure of the Influenza A Virus cRNA Promoter: Implications for Differential Recognition of Viral Promoter Structures by RNA-dependent RNA Polymerase | B-S Choi, C-J Park, G Varani, M-K Lee, S-H Bae |
4651 | 2001-05-09 | Chemical Shifts: 1 set |
Helix 7 Bovine Rhodopsin | Three Dimensional Structure of the Seventh Transmembrane Helical Domain of the G-Protein Receptor, Rhodopsin | A Albert, C Danis, G Choi, J Alderfer, P L Yeagle |
4488 | 2000-08-04 | Chemical Shifts: 2 sets |
DNA decamer duplex containing T-T (6-4) photoadduct | Solution structure of a DNA decamer duplex containing the stable 3' T.G base pair of the pyrimidine(6-4)pyrimidone photoproduct [(6-4) adduct]: implications for the highly specific 3' T --> C transition of the (6-4) adduct | B -S Choi, G -S Hwang, J H Lee |